Uncategorized
Eleven Biotherapeutics reports $7.6 million net loss in first quarter
Eleven Biotherapeutics reported a net loss applicable to common stockholders of $7.6 million, or $0.39 per share, in the first quarter compared with a net loss of $6.5 million, or $0.36 per share, in the same quarter of 2015, according to a press release. Revenue was reported at $0.2 million in the first quarter, which was unchanged from $0.2 million a year ago.